CI622D
AssetDevice
Dexamethasone-eluting cochlear implant electrode to reduce local inflammation and electrical impedance
- Stage
- Human trials
- Modality
- Device
- Target
- NR3C1
- Indications
- 4
- Trials
- 1
- Developers
- 1
Indications
4Bilateral hearing loss
Human trialsCOMPLETEDNCT06424262clinicaltrials.gov7 Oct 2026
Bilateral sensorineural hearing loss
Human trialsCOMPLETEDNCT06424262clinicaltrials.gov7 Oct 2026
Cochlear hearing loss
Human trialsCOMPLETEDNCT06424262clinicaltrials.gov7 Oct 2026
1 more
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors9
Every asset’s record: target, stage, trials and the evidence behind it.
See ProUpdated 7 Oct 2026 · 1 source